There are two transcription factors common between the AD-DS and DEX-CBC genesets.MTOR has been identified as a key target for therapeutic intervention in AD because of its regulation of several key signaling pathways: phosphoinositide 3-kinase (PI3-K)/protein kinase B (Akt), glycogen synthase kinase 3 [GSK-3], AMP-activated protein kinase (AMPK), and insulin/insulin-like growth factor 1 (IGF-1)55. This evidence concerns the gene MTOR and Alzheimer disease.